Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05892653
Status:
RECRUITING
Last Update Posted:
2023-07-24
First Post:
2023-05-18
Brief Title:
A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors
Sponsor:
ABM Therapeutics Shanghai Company Limited
Organization:
ABM Therapeutics Shanghai Company Limited
Organization Data
Organization:
ABM Therapeutics Shanghai Company Limited
Class:
INDUSTRY
Study ID:
ABM1310X1102C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ABM Therapeutics Shanghai Company Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None